Susquehanna Fundamental Investments LLC acquired a new stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,336,455 shares of the pharmacy operator's stock, valued at approximately $12,469,000. Susquehanna Fundamental Investments LLC owned approximately 0.15% of Walgreens Boots Alliance at the end of the most recent quarter.
Several other hedge funds also recently made changes to their positions in the business. First Financial Corp IN increased its stake in Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock valued at $25,000 after purchasing an additional 885 shares in the last quarter. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at approximately $26,000. Riverview Trust Co boosted its position in Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,590 shares during the period. Venturi Wealth Management LLC acquired a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $28,000. Finally, Independence Bank of Kentucky acquired a new position in Walgreens Boots Alliance in the fourth quarter valued at about $39,000. Institutional investors and hedge funds own 58.59% of the company's stock.
Walgreens Boots Alliance Stock Performance
NASDAQ WBA opened at $11.01 on Friday. The firm has a market cap of $9.52 billion, a P/E ratio of -1.08, a price-to-earnings-growth ratio of 1.31 and a beta of 0.67. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The company's 50 day moving average is $10.95 and its 200-day moving average is $10.22. Walgreens Boots Alliance, Inc. has a 12-month low of $8.08 and a 12-month high of $18.83.
Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion during the quarter, compared to analyst estimates of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business's revenue for the quarter was up 4.1% on a year-over-year basis. During the same period last year, the company earned $1.20 earnings per share. Sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.
Wall Street Analyst Weigh In
WBA has been the subject of a number of recent research reports. Evercore ISI increased their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. StockNews.com assumed coverage on shares of Walgreens Boots Alliance in a research report on Sunday. They set a "hold" rating on the stock. Wolfe Research upgraded shares of Walgreens Boots Alliance to a "hold" rating in a research note on Monday, February 24th. Truist Financial cut their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a research note on Friday, January 31st. Finally, Deutsche Bank Aktiengesellschaft downgraded Walgreens Boots Alliance from a "hold" rating to a "sell" rating and decreased their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating and two have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus price target of $10.59.
Read Our Latest Research Report on WBA
Walgreens Boots Alliance Profile
(
Free Report)
Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.
Featured Articles
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Walgreens Boots Alliance, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.
While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.